There are 702 resources available
304P - Clinical response to futibatinib in intrahepatic cholangiocarcinoma with acquired resistance to fibroblast growth factor receptor 2 inhibitors
Presenter: Simona Casalino
Session: Poster Display session
305P - Trastuzumab in combination with gemcitabine and cisplatin for treatment-naive HER2/neu-positive metastatic adenocarcinoma of gall bladder
Presenter: Raja Chhabra
Session: Poster Display session
306P - Comparison of lenvatinib plus pembrolizumab versus first-line systemic chemotherapy for advanced intrahepatic cholangiocarcinoma: A real-world retrospective study
Presenter: Zhenyun Yang
Session: Poster Display session
307P - Impact of inflammatory index on the prognosis of cholangiocarcinoma in Mexican population
Presenter: Marytere Herrera
Session: Poster Display session
308P - Real-world outcomes of 5-FU-based second-line therapy in patients with advanced biliary tract cancer refractory to gemcitabine and cisplatin-based treatment
Presenter: Kwonjae Lee
Session: Poster Display session
309P - Cholangiocarcinoma (CCA) in patients treated across lower Austria: A multicenter retrospective study
Presenter: Darius Morariu-Marina
Session: Poster Display session
310P - Pattern of care and outcomes in periampullary carcinoma in the Indian Subcontinent: A retrospective observational study
Presenter: Karthik J
Session: Poster Display session
311P - The forgotten tumor: Impact of histological subtype on overall survival of patients with ampullary adenocarcinoma in the Mexican population
Presenter: Elizabeth García
Session: Poster Display session
312P - Trastuzumab plus lapatinib for second-line treatment of human epidermal growth factor receptor 2-positive advanced biliary tract adenocarcinoma: A retrospective single-centre study
Presenter: Debapriya Mondal
Session: Poster Display session
313P - Disease and treatment patterns for advanced cholangiocarcinoma: A multicentric study from Portugal
Presenter: Joana Gonçalves
Session: Poster Display session